Doctors test custom cancer treatments based on tumor DNA
NCT ID NCT02624973
Summary
This trial is testing whether personalized treatment plans work better than standard care for high-risk breast cancer. Doctors analyze each patient's tumor genetics to choose the most promising drug combination before surgery. The study involves 200 participants and aims to understand why some tumors respond to treatment while others resist it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akershus University Hospital
Lørenskog, Akershus, Norway
-
Haukeland University Hospital
Bergen, Hordaland, 5021, Norway
-
Helse Fonna
Haugesund, Rogaland, Norway
-
Helse Førde
Førde, Sogn Og Fjordande, Norway
-
Helse Nord/UNN
Tromsø, Troms, Norway
-
Helse Stavanger
Stavanger, Rogaland, Norway
-
St. Olavs Hospital
Trondheim, Sør Trøndelag, Norway
Conditions
Explore the condition pages connected to this study.